0001209191-24-000825.txt : 20240104
0001209191-24-000825.hdr.sgml : 20240104
20240104165349
ACCESSION NUMBER: 0001209191-24-000825
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230517
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lowenthal Richard E
CENTRAL INDEX KEY: 0001378550
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 24512911
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-771-9307
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Silverback Therapeutics, Inc.
DATE OF NAME CHANGE: 20160412
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-05-17
0
0001671858
ARS Pharmaceuticals, Inc.
SPRY
0001378550
Lowenthal Richard E
C/O ARS PHARMACEUTICALS, INC.
11682 EL CAMINO REAL, SUITE 120
SAN DIEGO
CA
92130
1
1
1
0
President and CEO
0
Common Stock
2023-05-17
4
G
0
1050000
0.00
D
4126822
D
Common Stock
2023-05-17
4
G
0
1050000
0.00
A
1050000
I
By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Common Stock
2023-05-17
4
G
0
1050000
0.00
D
3276854
I
By spouse
Common Stock
2023-05-17
4
G
0
1050000
0.00
A
2100000
I
By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Common Stock
1772850
I
By Richard E. Lowenthal Charitable Remainder Unitrust Dated January 7, 2020
Common Stock
1772850
I
By Sarina Tanimoto Charitable Remainder Unitrust Dated January 7, 2020
Stock option (right to buy)
5.58
2024-01-02
4
A
0
880000
0.00
A
2034-01-01
Common Stock
880000
880000
D
Stock option (right to buy)
5.58
2024-01-02
4
A
0
300000
0.00
A
2034-01-01
Common Stock
300000
300000
I
By spouse
These shares are held in a trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust.
The Reporting Person is trustee of the trust.
The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.
/s/ Kathleen Scott, Attorney-in-Fact
2024-01-04